Should CSL (ASX:CSL) be your next dividend share?

Should CSL Limited (ASX: CSL) be your next ASX dividend share? The 1.04% yield may look paltry, but sometimes it's the growth that counts.

| More on:
A man happily kisses a $50 note scrunched up in his hands representing the best ASX dividend stocks in Australia today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Limited (ASX: CSL) has never had much of a reputation as an ASX dividend share. Especially when compared to its companions in the upper echelons of the S&P/ASX 200 Index (ASX: XJO). Think about it. CSL is now the third-largest ASX 200 share by market capitalisation. Gold and silver go to Commonwealth Bank of Australia (ASX: CBA) and BHP Group Ltd (ASX: BHP). And below CSL are the other 3 remaining big banks.

All of these other companies are (or at least were, pre-COVID) dividend heavyweights.

And yet CSL has never enjoyed such a reputation. Even today, the company offers a trailing dividend yield of 1.04% – not really 'set the world on fire' stuff. And that's not even following a COVID-induced dividend cut from last year. In fact, 2020 saw CSL dole out its highest dividends in history with a combined US$2.02 per share payout. 2021 so far has seen an interim dividend of US$1.04 per share, healthily exceeding 2020's interim dividend of 95 cents.

CSL's dividend growth

CSL has been around in some form for over a hundred years. But it only paid its first dividends in 2013. That was a combined payment of US$1.02 per share. That means that CSL has grown its annual dividend since 2013 by a compounded annual growth rate of 10.25% per annum.

Here's an interesting number for you. Back in October 2013, when CSL paid its first final dividend, CSL shares were going for roughly $66 apiece. Using today's exchange rate, that would have equated to a rough annual yield of around 2% at the time for an investor who picked up CSL back then. But if that investor held those CSL shares until today, the yield they would have gotten on their original investment would be around 4% today with CSL's dividend growth.

That's the power of a compounding growth rate. If CSL continues to increase its dividends by an average of 10.25% every year, that yield-on-cost will only grow larger, and exponentially so, in the years ahead.

So although a 1.04% trailing dividend yield might look a little paltry, CSL's history of strong dividend growth proves that sometimes it's not just size that matters.

Should you invest $1,000 in Dorsavi Ltd right now?

Before you buy Dorsavi Ltd shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Dorsavi Ltd wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man slumps crankily over his morning coffee as it pours with rain outside.
Healthcare Shares

Why is this ASX 300 stock crashing 18% today?

Investors are rushing to the exits. But why? Let's look into things.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are CSL shares at risk from the Trump tariffs?

How exposed are CSL shares to potential Trump medicinal tariffs?

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

What did CSL have to say at Macquarie's 2025 conference?

Does this business have a healthy growth outlook?

Read more »

smiling health care workers in a medical setting
Healthcare Shares

Sonic Healthcare shares are down more than 40% since 2021. Will its AI initiative be the catalyst for a turnaround?

Could AI spark a recovery for this ASX healthcare stock?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Why is this ASX All Ords stock jumping 7% today?

This stock is ending the week strongly. Let's find out what is getting investors excited.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

Two doctors give the thumbs up to an x-ray
Healthcare Shares

Buying the dip: $10,000 invested in Pro Medicus shares on 7 April is now worth…

This healthcare stock has boomed over the past month. 

Read more »